Doç. Dr. Cem Mirili

Hekim Özgeçmişi

• Doğum Yeri: -
• Doğum Tarihi: -

Eğitim Bilgileri

• Medikal Onkoloji (Yandal Uzmanlık): Çukurova Üniversitesi Tıp Fakültesi
• İç Hastalıkları (Anadal Uzmanlık): İzmir Bozyaka Eğitim ve Araştırma Hastanesi
• Tıp Fakültesi: EGE Üniversitesi Tıp Fakültesi

Uzmanlık Alanı

• Onkoloji
• Meme Kanseri
• Akciğer Kanseri
• Mide Kanseri
• Lenfoma
• Kolorektal Kanserler
• Jinekolojik Kanserler
• Ürogenital Kanserler
• Kanser Hastalarında Beslenme
• Tüm erişkin kanser türlerinde erken teşhis ve tedavi planlama
• Kemoterapi hazırlama ve uygulama birimleri
• İmmunoterapi hazırlama ve uygulama
• Hedefe yönelik Tedaviler (Akıllı hap ve iğne tedavileri)
• Palyatif destek ve tedavi
• Ağrı Kontrolü ve Beslenme Önerileri
• Radyolojik Görüntülemeler
• --Tomografi, Manyetik Rezonans (MR), Direk Grafiler)
• --PET-CT, Kemik Sintigrafisi, Kemik Dansitometrisi
• Cerrahi tedaviler

Mesleki Deneyim

• Çukurova Üniversitesi Tıbbi Onkoloji Bölümü (Adana)
• Atatürk Üniversitesi Tıbbi Onkoloji Bölümü (Erzurum)
• Atatürk Üniversitesi Hemşirelik Bölümü (Eğitmen) (Erzurum)
• Tortum Devlet Hastanesi İç Hastalıkları Bölümü (Erzurum)

Yayınlar

• MiRiLi C, GÜNEY IB, PAYDAS S, et al.(2019). Prognostic significance of neutrophil/lymphocyte ratio (NLR) and correlation with PET–CT metabolic parameters in small cell lung cancer (SCLC). International Journal of Clinical Oncology, 24(2), 168-178., Doi: 10.1007/s10147-018-1338-8,
• MIRILI C,YILMAZ A, DEMİRKAN S, et al.(2019). Clinical significance of prognostic nutritional index (PNI) in malignant melanoma. International Journal of Clinical Oncology, 24(10), 1301-1310., Doi: 1007/S10147-019-01461-7,
• MIRILI C,PAYDAS S,KORKMAZ KAPUKAYA TUBA, YILMAZ A. (2019). Systemic immune- inflammation index predicting survival outcome in patients with classical Hodgkin lymphoma. Biomarkers in Medicine, 13(18), 1565-1575., Doi: 2217/bmm-2019-0303,
• MİRİLİ C,PAYDAS S,KILIÇ BAĞIR EMİNE,Şeydaoğlu gülşah,OĞUL ALİ,GOKCAY S,BUYUKSİMSEK M,yetisir abdullah evren,karaalioğlu bilgin,TOHUMCUO LU MERT,ERG N MELEK,ZORLUDEM R SUZAN (2020). Prognostic significance of EGFR, MUC1 and PD- L1 expressions in cases with triple negative breast cancer. Journal of BUON, 25(1), 159-167.
• MİRİLİ C, PAYDAS S,GÜNEY iSA BURAK, OĞUL A,GOKCAY S,BÜYÜKSİMSEK MAHMUT,YetiSir Abdullah Evren, KARAALİOĞLU BİLGİN, TOHUMCUOĞLU MERT,SEYDAOĞLU GÜLŞAH (2019). Assessment of potential predictive value of peripheral blood inflammatory indexes in 26 cases with soft tissue sarcoma treated by pazopanib: a retrospective study. Cancer ManagementandResearch,11,3445-3453.,Doi:2147/CMAR.S191199,
• YILMAZ A, MİRİLİ C, TEKİN SALİM BASOL, BİLİCİ M (2020). The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study. IRISH JOURNAL OF MEDICAL SCIENCE, 189(1), 91-102., Doi: 1007/s11845-019-02153-x,
• YILMAZ A, MİRİLİ C, BİLİCİ M,TEKİN SALİM BAŞOL (2019). A Novel Predictor in Patients With Gastrointestinal Stromal Tumors: Systemic Immune-Inflammation Index (SII). Journal of BUON, 24(5), 2127-2135.
• YILMAZ A, MİRİLİ C, BİLİCİ M,TEKİN SALİM BAŞOL (2020). Colorectal cancer in Lynch syndrome associated with PMS2 and MSH6 mutations. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 35(2), 351-353, Doi: 10.1007/s00384-019-03454-4
• PAYDAS S,OĞUL A, MİRİLİ C, GÖKÇAY S. (2019). Correction to: Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma. ANNALS OF HEMATOLOGY, 98(7), 1803-1803., Doi: 1007/S00277-019-03720-Z,
• TATAR E, MİRİLİ C, IŞIKYAKAR T, GÜVERCİN G, ÖZAY E, AŞÇI (2016). The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3–5 chronic kidney disease. Acta Clinica Belgica, 71(4), 221-226., Doi: 10.1080/17843286.2016.1159797,
• BÜYÜKSİMSEK M, Togun M,KARA İO, BİŞGİN A,BOGA İ, TOHUMCUOĞLU M, OĞUL A, Yetisir AE, ŞAHİN B, MİRİLİ C (2019). Results of liquid biopsy studies by next generation sequencing in patients with advanced stage non-small cell lung cancer: Single center experience from Turkey. Balkan Journal of Medical Genetics, 22(2), 17-24., Doi: 10.2478/bjmg-2019-0016,
• MİRİLİ C, PAYDAS S, OĞUL A, GOKCAY S, BUYUKSİMSEK M, Yetisir AE , TOHUMCUOĞLU M, KaraalioĞlu B(2020). Dynamic Prognostic Nutritional Index could be a novel predictor of survival in Lung Cancer patients treated with nivolumab. The Annals of Clinical and Analytical Medicine, 11(supplement 1), 1-6., Doi: 10.4328/ACAM20025,
• MİRİLİ C, YÜCE KÇ, YILMAZ A, BİLİCİ M, TEKİN SB, tatar A, YAKAR Ö, ERCOŞKUN P (2019). Clinical results and importance of next- generation sequencing (NGS) in detecting targeted mutations in the treatment of metastatic Lung Cancer: Single center initial results. Medical Science and Discovery, 6(12), 327-332., Doi: 36472/msd.v6i12.330,
• MİRİLİ C, BİLİCİ M (2020). Inflammatory prognostic markers in endometrial carcinoma: Systemic immune-inflammation index and prognostic nutritional index. Medical Science and Discovery, 7(1), 351-359., Doi: 36472/msd.v7i1.339
• MİRİLİ C, PAYDAS S,OĞUL A,GOKCAY S (2018). Acute promyelocytic leukemia after anthracycline containing chemotherapy for breast cancer: Case report and review of the literature. Journal of Oncological Sciences, 4(1), 62-64., Doi: 1016/j.jons.2018.02.001,
• MİRİLİ C, PAYDAS S,OĞUL A,GOKCAY S (2018). Acute promyelocytic leukemia after anthracycline containing chemotherapy for breast cancer: Case report and review of the literature. Journal of Oncological Sciences, 4(1), 62-64., Doi: 1016/j.jons.2018.02.001,
• BUYUKSİMSEK M, PAYDAS S, GÜMÜRDÜLÜ D, MİRİLİ C, OĞUL A, yetiSir abdullah evren, TOHUMCUOĞLU M (2019). Atypical Radiologic Image Characterized by Cavitary Lung Lesions in a Case of Hodgkin Lymphoma. Turkish Journal of Hematology, 36(1), 60-61., Doi: 10.4274/tjh.galenos.2018.2018.0115,
• SARER YBP, KocabaS G, MİRİLİ C, SUNER KA, AKŞİT M, Yürekli İ, Kutbay NÖ, Yıdırım B, Bozkaya G (2018). Circulating Lipocalin-2 Levels Are Associated With Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels In Type 2 Diabetic Patients. Journal of Endocrinology and Diabetes, 5(5), 1-7., Doi: 10.15226/2374-6890/5/5/001116, (
• BUYUKSİMSEK M, KARA İO, yetisir abdullah evren, MİRİLİ C, GOKCAY S, OĞUL A,TOHUMCUOğLU M, SÜMBÜL HE, büyüksimsek k (2018). Metastatic Renal Cell Carcinoma Case Report Undergoing Multiple Treatment Options and Review of Literature . Eurasian Journal of Medical Investigation, 2(2), 101-103., Doi: 14744/ejmi.2018.76376,
• PAYDA S, YETİSİR EVREN, MİRİLİ C, İSMAYİLOV ELÇİN, BÜYÜKSİMSEK M, OĞUL A, KILIÇ BE, ERGİN M (2018). G-CSF related hemophagocytos s in a case with lymhphoma. Clinical Research and Trials, 4(1), 1-2., Doi: 10.15761/CRT.1000203,

Onkoloji Birim Doktorları

Özel Adana Ortadoğu Hastanesi’nde görev yapan deneyimli Onkoloji Birim Doktorlarını aşağıdan detaylı bir şekilde inceleyebilirsiniz.